Astrantus’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Astrantus’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	$251K	Buy	+3,100	New	+$262K	0.42%	144

Other funds holding SYNH

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Astrantus's SYNH Position: Q1 2022 in Review

Astrantus opened a new position in Syneos Health, Inc. Class A Common Stock (SYNH) in Q1 2022: 3,100 shares worth $251K. The stake represents 0.42% of the portfolio and ranks #144 among its holdings.

365 funds tracked by Wall St. Rank hold SYNH as of Q1 2022.

Astrantus held 3,100 shares of Syneos Health, Inc. Class A Common Stock worth $251K as of Q1 2022.
Syneos Health, Inc. Class A Common Stock was a new Astrantus position in Q1 2022.
Syneos Health, Inc. Class A Common Stock made up 0.42% of Astrantus's portfolio in Q1 2022, its #144 holding.
365 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q1 2022.

Based on Astrantus's 13F filing for Q1 2022, filed 11 May 2022.